Therapeutically effective topical application of ST1435
US5651973A · kind A · utility
23Cited by
11References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 1992 |
| Grant date | Jul 29, 1997 |
| Priority date | — |
| Expiry date | Nov 30, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The progesterone analog ST1435 has now been found to attain therapeutically effective levels upon topical application to the skin. ST1435 can be administered topically either in liquid or semisolid base such as a cream or gel or in a solid base such as a transdermal device such as a disk, band patch or bracelet. The invention further provides topical applications suitable for transdermal delivery of therapeutically effective amounts of ST1435.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.